Neuromyelitis Optica Testing and Treatment: Availability and Affordability in 60 Countries
ConclusionsThere is a gap in access to diagnostic testing for NMO in non-high-income countries, even in countries where acute and immunosuppressive treatment for NMO are available.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: African Health | Brain | Expenditures | France Health | Methylprednisolone | Multiple Sclerosis | Neurology | Prednisone | Rituxan | Spain Health